董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Joseph M. Hogan | 男 | President, Chief Executive Officer and Director | 66 | 2895.24万美元 | 22.17 | 2024-04-09 |
| Kevin J. Dallas | 男 | Independent Director | 60 | 36.83万美元 | 1.22 | 2024-04-09 |
| Susan E. Siegel | 女 | Independent Director | 63 | 35.98万美元 | 0.68 | 2024-04-09 |
| Mojdeh Poul | 女 | Independent Director | 61 | 14.63万美元 | 未持股 | 2024-04-09 |
| Anne Myong | 女 | Independent Director | 56 | 38.47万美元 | 0.59 | 2024-04-09 |
| Joseph Lacob | 男 | Independent Director | 68 | 36.48万美元 | 13.20 | 2024-04-09 |
| George J. Morrow | 男 | Independent Director | 72 | 38.18万美元 | 0.44 | 2024-04-09 |
| Kevin T. Conroy | 男 | Independent Director | 58 | 14.63万美元 | 未持股 | 2024-04-09 |
| C. Raymond Larkin, Jr. | 男 | Independent Director | 75 | 49.97万美元 | 2.04 | 2024-04-09 |
| Andrea L. Saia | 女 | Independent Director | 66 | 38.18万美元 | 1.34 | 2024-04-09 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Joseph M. Hogan | 男 | President, Chief Executive Officer and Director | 66 | 2895.24万美元 | 22.17 | 2024-04-09 |
| John F. Morici | 男 | Chief Financial Officer and Executive Vice President, Global Finance | 57 | 556.29万美元 | 1.30 | 2024-04-09 |
| Stuart Hockridge | 男 | Executive Vice President, Global Human Resources | 52 | 341.25万美元 | 0.97 | 2024-04-09 |
| Julie Coletti | 女 | Executive Vice President, Chief Legal and Regulatory Officer | 56 | 427.59万美元 | 0.46 | 2024-04-09 |
| Emory M. Wright | 男 | Executive Vice President, Global Operations | 54 | 424.92万美元 | 1.53 | 2024-04-09 |
董事简历
中英对照 | 中文 | 英文- Joseph M. Hogan
-
Joseph M. Hogan ， Align公司总裁兼首席执行官，2015年至今。2008-2013年，ABB公司的首席执行官。2000-2008年通用电气医疗保健公司首席执行官。
Joseph M. Hogan,President and CEO, Align Technology Inc. (dental technology company) CEO, ABB at Cutlass Capital (technology company),2015 - Present.Various Positions including CEO of GE Healthcare, General Electric (a medical technology company),Prior.Supervisory Board of avateramedical N.V. (2019-2021).B.S. in Business and Economics from Geneva College;M.B.A. from Robert Morris University. - Joseph M. Hogan ， Align公司总裁兼首席执行官，2015年至今。2008-2013年，ABB公司的首席执行官。2000-2008年通用电气医疗保健公司首席执行官。
- Joseph M. Hogan,President and CEO, Align Technology Inc. (dental technology company) CEO, ABB at Cutlass Capital (technology company),2015 - Present.Various Positions including CEO of GE Healthcare, General Electric (a medical technology company),Prior.Supervisory Board of avateramedical N.V. (2019-2021).B.S. in Business and Economics from Geneva College;M.B.A. from Robert Morris University.
- Kevin J. Dallas
-
Kevin J. Dallas，Wind River Systems，Inc.是一家软件开发公司，现任总裁兼首席执行官；董事会成员，2020年至今。微软公司，一家软件开发和解决方案公司，公司副总裁，云与人工智能业务开发，1996-2020年。NVIDIA公司和国家半导体公司，现为德克萨斯仪器公司，1996年及之前。B.S.c。电子电气工程专业毕业于斯塔福德郡大学，特伦特河畔斯托克，斯塔福德郡，英国。
Kevin J. Dallas has served as the President and Chief Executive Officer at Wind River Systems, Inc., a company whose software deploys IoT systems, since 2020. Mr. Dallas previously served as the Corporate Vice President for Cloud & AI Business Development for Microsoft from 1996 to 2020 helping to enable the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. Prior to working with Microsoft, he held roles at NVIDIA Corporation and National Semiconductor now Texas Instruments Inc. in the U.S., Europe, and the Middle East.Mr. Dallas earned a B.S.c. degree in Electrical and Electronic Engineering from Staffordshire University, Stoke-on-Trent, Staffordshire, England. - Kevin J. Dallas，Wind River Systems，Inc.是一家软件开发公司，现任总裁兼首席执行官；董事会成员，2020年至今。微软公司，一家软件开发和解决方案公司，公司副总裁，云与人工智能业务开发，1996-2020年。NVIDIA公司和国家半导体公司，现为德克萨斯仪器公司，1996年及之前。B.S.c。电子电气工程专业毕业于斯塔福德郡大学，特伦特河畔斯托克，斯塔福德郡，英国。
- Kevin J. Dallas has served as the President and Chief Executive Officer at Wind River Systems, Inc., a company whose software deploys IoT systems, since 2020. Mr. Dallas previously served as the Corporate Vice President for Cloud & AI Business Development for Microsoft from 1996 to 2020 helping to enable the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. Prior to working with Microsoft, he held roles at NVIDIA Corporation and National Semiconductor now Texas Instruments Inc. in the U.S., Europe, and the Middle East.Mr. Dallas earned a B.S.c. degree in Electrical and Electronic Engineering from Staffordshire University, Stoke-on-Trent, Staffordshire, England.
- Susan E. Siegel
-
Susan E. Siegel，通用电气和GE Business Innovations，分别是全球数字和工业解决方案提供商、前首席创新官和前首席执行官，分别于2017年至2019年任职。GE Ventures，通用电气的风险投资子公司，2012-2017年任首席执行官。Mohr Davidow Ventures，一家医疗和生命科学投资公司，VC普通合伙人，2006-2012年。Affymetrix，Inc.，一家DNA微阵列产品供应商，总裁和董事会成员，1998-2006年。波多黎各大学生物学学士学位，波士顿大学医学院生物化学和分子生物学硕士学位。
Susan E. Siegel,Senior Lecturer, MIT Sloan School of Management (since 2019);Chief Innovation Officer of General Electric (GE) and CEO of GE Business Innovations (GE's growth and innovation business), and CEO of GE Ventures (subsumed into Chief Innovation Officer role) (2012 – 2019);General Partner, Mohr Davidow Ventures (2006 – 2012);President and Board Member of Affymetrix, Inc. (1998 – 2006).B.S. in Biology from University of Puerto Rico;M.S. in Biochemistry and Molecular Biology from Boston University Medical School. - Susan E. Siegel，通用电气和GE Business Innovations，分别是全球数字和工业解决方案提供商、前首席创新官和前首席执行官，分别于2017年至2019年任职。GE Ventures，通用电气的风险投资子公司，2012-2017年任首席执行官。Mohr Davidow Ventures，一家医疗和生命科学投资公司，VC普通合伙人，2006-2012年。Affymetrix，Inc.，一家DNA微阵列产品供应商，总裁和董事会成员，1998-2006年。波多黎各大学生物学学士学位，波士顿大学医学院生物化学和分子生物学硕士学位。
- Susan E. Siegel,Senior Lecturer, MIT Sloan School of Management (since 2019);Chief Innovation Officer of General Electric (GE) and CEO of GE Business Innovations (GE's growth and innovation business), and CEO of GE Ventures (subsumed into Chief Innovation Officer role) (2012 – 2019);General Partner, Mohr Davidow Ventures (2006 – 2012);President and Board Member of Affymetrix, Inc. (1998 – 2006).B.S. in Biology from University of Puerto Rico;M.S. in Biochemistry and Molecular Biology from Boston University Medical School.
- Mojdeh Poul
-
Mojdeh Poul，自2021年2月以来，她一直是史丹利百得公司的董事。她领导3M的医疗保健业务集团，服务于全球医疗保健行业，包括医疗解决方案、口腔护理、分离和净化科学、健康信息系统、药物输送系统和食品安全。她的3M职业生涯始于2011年，当时她加入医疗保健业务集团，担任Critical and Chronic Care Solutions部门的全球营销负责人。在接下来的几年里，她曾担任食品安全和感染预防业务的全球领导职务，2016年被任命为3M Canada的总裁和总经理，2018年被任命为3M的安全与图形业务集团的执行副总裁。加入3M之前，她曾在Medtronic和Boston Scientific担任多个领导职务，负责不断增加的责任。她领导的团队跨越不同的职能、业务和地域，包括高度监管的行业和业务需要强大的市场开发专业知识。她是审计委员会和公司治理委员会的成员。
Mojdeh Poul,was most recently executive vice president and group president of 3M Health Care where she was responsible for its global P&L, strategy, research & development, manufacturing and commercial operations. During her tenure at 3M, Ms. Poul held leadership roles, including executive vice president of Safety & Graphics Business Group, president of 3M Canada, and president of two divisions within the 3M Health Care Business Group. Prior to 3M, Ms. Poul held several leadership roles of increasing responsibility with Medtronic and Boston Scientific, two leading global medical technology companies. Prior to this, Ms. Poul held engineering positions with General Electric Plastics. Ms. Poul currently serves as a director of iRhythm Technologies and Stanley Black and Decker. Ms. Poul holds a M.B.A. degree from University of North Carolina, Chapel Hill, and M.Eng. and B.S. degrees in Mechanical Engineering from the University of Louisville. - Mojdeh Poul，自2021年2月以来，她一直是史丹利百得公司的董事。她领导3M的医疗保健业务集团，服务于全球医疗保健行业，包括医疗解决方案、口腔护理、分离和净化科学、健康信息系统、药物输送系统和食品安全。她的3M职业生涯始于2011年，当时她加入医疗保健业务集团，担任Critical and Chronic Care Solutions部门的全球营销负责人。在接下来的几年里，她曾担任食品安全和感染预防业务的全球领导职务，2016年被任命为3M Canada的总裁和总经理，2018年被任命为3M的安全与图形业务集团的执行副总裁。加入3M之前，她曾在Medtronic和Boston Scientific担任多个领导职务，负责不断增加的责任。她领导的团队跨越不同的职能、业务和地域，包括高度监管的行业和业务需要强大的市场开发专业知识。她是审计委员会和公司治理委员会的成员。
- Mojdeh Poul,was most recently executive vice president and group president of 3M Health Care where she was responsible for its global P&L, strategy, research & development, manufacturing and commercial operations. During her tenure at 3M, Ms. Poul held leadership roles, including executive vice president of Safety & Graphics Business Group, president of 3M Canada, and president of two divisions within the 3M Health Care Business Group. Prior to 3M, Ms. Poul held several leadership roles of increasing responsibility with Medtronic and Boston Scientific, two leading global medical technology companies. Prior to this, Ms. Poul held engineering positions with General Electric Plastics. Ms. Poul currently serves as a director of iRhythm Technologies and Stanley Black and Decker. Ms. Poul holds a M.B.A. degree from University of North Carolina, Chapel Hill, and M.Eng. and B.S. degrees in Mechanical Engineering from the University of Louisville.
- Anne Myong
-
Anne Myong，Aura Financial LLC，一家金融科技和消费贷款公司，前首席执行官兼首席财务官，2020年。沃尔玛全球电子商务，一家跨国消费零售和电子商务公司，高级副总裁兼首席财务官，沃尔玛中国零售高级副总裁兼首席财务官，2011-2017。安捷伦科技中国公司，副总裁兼首席财务官，2006-2011。工商管理硕士。哈佛商学院学士学位。杰姆斯麦迪逊大学计算机信息系统学位。
Anne Myong,Aura Financial LLC, a financial technology and consumer lending company,Former CEO & CFO,2020.Walmart Global eCommerce, a multinational consumer retail and e-commerce corporation,Senior Vice President and Chief Financial Officer, and Senior Vice President, Chief Financial and Administrative Officer of Walmart China Retail,2011-2017.Agilent Technologies China,Vice President and CFO,2006-2011.M.B.A. degree from Harvard Business School.B.B.A. degree in Computer Information Systems from James Madison University. - Anne Myong，Aura Financial LLC，一家金融科技和消费贷款公司，前首席执行官兼首席财务官，2020年。沃尔玛全球电子商务，一家跨国消费零售和电子商务公司，高级副总裁兼首席财务官，沃尔玛中国零售高级副总裁兼首席财务官，2011-2017。安捷伦科技中国公司，副总裁兼首席财务官，2006-2011。工商管理硕士。哈佛商学院学士学位。杰姆斯麦迪逊大学计算机信息系统学位。
- Anne Myong,Aura Financial LLC, a financial technology and consumer lending company,Former CEO & CFO,2020.Walmart Global eCommerce, a multinational consumer retail and e-commerce corporation,Senior Vice President and Chief Financial Officer, and Senior Vice President, Chief Financial and Administrative Officer of Walmart China Retail,2011-2017.Agilent Technologies China,Vice President and CFO,2006-2011.M.B.A. degree from Harvard Business School.B.B.A. degree in Computer Information Systems from James Madison University.
- Joseph Lacob
-
Joseph Lacob自1997年8月担任Align 公司董事，自1987年出任风险投资公司Kleiner Perkins Caufield & Byers （KPCB）合作伙伴。2011年， Lacob 收购了全美篮球协会Golden State勇士队。他现任 勇士队股东兼首席执行官。在1987年加入KPCB之前， Lacob是 FHP国际Cetus 公司 （现Chiron）行政经理，公司是一家医疗保健组织，同时也担任Booz, Allen & Hamilton 公司管理顾问。此前他任职于Orexigen 诊疗公司董事会成员，该公司是一家研究肥胖症治疗以及相关药物研发的生物制药公司。Lacob同时也是个人、家庭和小企业健康保险在线服务公司eHealth 股份有限公司董事会成员。
Joseph Lacob acquired The Golden State Warriors of the National Basketball Association in 2010 and is currently the Managing Partner and CEO of the Warriors. From 1987 to 2018 he was a partner of Kleiner Perkins Caufield & Byers KPCB, a venture capital firm. Prior to joining KPCB, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization, and Booz, Allen & Hamilton, a management consulting firm.Mr. Lacob earned an M.B.A. from Stanford University, a Masters in Public Health from the University of California at Los Angeles and a B.S. in Biological Sciences from the University of California at Irvine. - Joseph Lacob自1997年8月担任Align 公司董事，自1987年出任风险投资公司Kleiner Perkins Caufield & Byers （KPCB）合作伙伴。2011年， Lacob 收购了全美篮球协会Golden State勇士队。他现任 勇士队股东兼首席执行官。在1987年加入KPCB之前， Lacob是 FHP国际Cetus 公司 （现Chiron）行政经理，公司是一家医疗保健组织，同时也担任Booz, Allen & Hamilton 公司管理顾问。此前他任职于Orexigen 诊疗公司董事会成员，该公司是一家研究肥胖症治疗以及相关药物研发的生物制药公司。Lacob同时也是个人、家庭和小企业健康保险在线服务公司eHealth 股份有限公司董事会成员。
- Joseph Lacob acquired The Golden State Warriors of the National Basketball Association in 2010 and is currently the Managing Partner and CEO of the Warriors. From 1987 to 2018 he was a partner of Kleiner Perkins Caufield & Byers KPCB, a venture capital firm. Prior to joining KPCB, Mr. Lacob was an executive with Cetus Corporation (now Chiron), FHP International, a health maintenance organization, and Booz, Allen & Hamilton, a management consulting firm.Mr. Lacob earned an M.B.A. from Stanford University, a Masters in Public Health from the University of California at Los Angeles and a B.S. in Biological Sciences from the University of California at Irvine.
- George J. Morrow
-
George J. Morrow曾担任全球生物技术公司Amgen Inc.，2003-2011年；Global Commercial Operations执行副总裁和Worldwide Sales and Marketing执行副总裁（2001-2003年）。1992年至2001年，Morrow先生在GlaxoSmithKline Inc.及其子公司担任多个领导职务，包括Glaxo Wellcome Inc.总裁兼首席执行官。Morrow在杜克大学获得了工商管理硕士学位，在布林莫尔学院获得了生物化学硕士学位，在长岛大学南安普顿学院获得了化学学士学位。
George J. Morrow served as the Executive Vice President, Global Commercial Operations 2003-2011 and Executive Vice President of Worldwide Sales and Marketing (2001-2003) at Amgen Inc., a global biotechnology company. From 1992 to 2001 Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc.Mr. Morrow earned an M.B.A. from Duke University, an M.S. degree in Biochemistry from Bryn Mawr College and a B.S. degree in Chemistry from Southampton College, Long Island University. - George J. Morrow曾担任全球生物技术公司Amgen Inc.，2003-2011年；Global Commercial Operations执行副总裁和Worldwide Sales and Marketing执行副总裁（2001-2003年）。1992年至2001年，Morrow先生在GlaxoSmithKline Inc.及其子公司担任多个领导职务，包括Glaxo Wellcome Inc.总裁兼首席执行官。Morrow在杜克大学获得了工商管理硕士学位，在布林莫尔学院获得了生物化学硕士学位，在长岛大学南安普顿学院获得了化学学士学位。
- George J. Morrow served as the Executive Vice President, Global Commercial Operations 2003-2011 and Executive Vice President of Worldwide Sales and Marketing (2001-2003) at Amgen Inc., a global biotechnology company. From 1992 to 2001 Mr. Morrow held multiple leadership positions at GlaxoSmithKline Inc. and its subsidiaries, including President and Chief Executive Officer of Glaxo Wellcome Inc.Mr. Morrow earned an M.B.A. from Duke University, an M.S. degree in Biochemistry from Bryn Mawr College and a B.S. degree in Chemistry from Southampton College, Long Island University.
- Kevin T. Conroy
-
Kevin T. Conroy，2009年4月以来曾担任Epizyme, Inc.的总裁兼首席执行官，2009年3月以来担任董事，2014年3月以来担任董事会主席。他担任 Third Wave 技术公司总裁兼首席执行官，一家分子诊断公司，从2005年12月直到Third Wave在2008年7月被Hologic公司收购。他在2004年7月加入了Third Wave，担任其总顾问直到2005年12月。加入Third Wave之前，他担任GE Healthcare（医学成像和诊断公司）和General Electric Company的一个部门的知识产权法律顾问。在加入GE Healthcare之前，他是两个早期风投支持的科技公司的首席运营官。担任这些职位之前，他是两家芝加哥律师事务所McDermott Will & Emery和 Pattishall, McAuliffe, Newbury, Hilliard and Geraldson的一个知识产权诉讼律师，他是一个合作伙伴。他获得了密歇根州立大学电子工程学士学位和密歇根大学的法律学位。
Kevin T. Conroy,has served as a director since February 2017. Mr. Conroy is currently the President, Chief Executive Officer and Chairman of the Board of Directors of Exact Sciences Corporation, or Exact Sciences, a molecular diagnostics company. Mr. Conroy was named Chairman of the Board of Exact Sciences in March 2014 and has served as President and Chief Executive Officer since April 2009 and as a director since March 2009. Prior to joining Exact Sciences, Mr. Conroy served in multiple executive leadership positions at Third Wave Technologies, or Third Wave, a molecular diagnostic testing company, including President and Chief Executive Officer from December 2005 until the acquisition of Third Wave by Hologic, Inc. in July 2008. He joined Third Wave in July 2004 and served as General Counsel from October 2004 until December 2005. Prior to Third Wave, Mr. Conroy served as Intellectual Property Counsel at GE Healthcare, a medical imaging and diagnostics company and a division of General Electric Company. Before joining GE Healthcare, Mr. Conroy was the chief operating officer of two early-stage, venture-backed technology companies. Prior to that, he was an intellectual property litigator at McDermott Will & Emery and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. Mr. Conroy received a B.S. in electrical engineering from Michigan State University and a J.D. from the University of Michigan Law School. - Kevin T. Conroy，2009年4月以来曾担任Epizyme, Inc.的总裁兼首席执行官，2009年3月以来担任董事，2014年3月以来担任董事会主席。他担任 Third Wave 技术公司总裁兼首席执行官，一家分子诊断公司，从2005年12月直到Third Wave在2008年7月被Hologic公司收购。他在2004年7月加入了Third Wave，担任其总顾问直到2005年12月。加入Third Wave之前，他担任GE Healthcare（医学成像和诊断公司）和General Electric Company的一个部门的知识产权法律顾问。在加入GE Healthcare之前，他是两个早期风投支持的科技公司的首席运营官。担任这些职位之前，他是两家芝加哥律师事务所McDermott Will & Emery和 Pattishall, McAuliffe, Newbury, Hilliard and Geraldson的一个知识产权诉讼律师，他是一个合作伙伴。他获得了密歇根州立大学电子工程学士学位和密歇根大学的法律学位。
- Kevin T. Conroy,has served as a director since February 2017. Mr. Conroy is currently the President, Chief Executive Officer and Chairman of the Board of Directors of Exact Sciences Corporation, or Exact Sciences, a molecular diagnostics company. Mr. Conroy was named Chairman of the Board of Exact Sciences in March 2014 and has served as President and Chief Executive Officer since April 2009 and as a director since March 2009. Prior to joining Exact Sciences, Mr. Conroy served in multiple executive leadership positions at Third Wave Technologies, or Third Wave, a molecular diagnostic testing company, including President and Chief Executive Officer from December 2005 until the acquisition of Third Wave by Hologic, Inc. in July 2008. He joined Third Wave in July 2004 and served as General Counsel from October 2004 until December 2005. Prior to Third Wave, Mr. Conroy served as Intellectual Property Counsel at GE Healthcare, a medical imaging and diagnostics company and a division of General Electric Company. Before joining GE Healthcare, Mr. Conroy was the chief operating officer of two early-stage, venture-backed technology companies. Prior to that, he was an intellectual property litigator at McDermott Will & Emery and Pattishall, McAuliffe, Newbury, Hilliard and Geraldson, where he was a partner. Mr. Conroy received a B.S. in electrical engineering from Michigan State University and a J.D. from the University of Michigan Law School.
- C. Raymond Larkin, Jr.
-
C. Raymond Larkin, Jr.自2008年10月担任HeartWare的董事，自2010年6月担任董事会主席。Larkin先生在2004年3月加入Align Technology, Inc.（纳斯达克（Nasdaq）代码：ALGN）董事会，自2006年6月担任董事会主席。Align Technology专注于新型畸齿矫正产品的设计、生产和市场营销。他是Neuropace和TherOx的董事，前者是一家私有的可植入设备的生产商，这些设备主要用于治疗神经紊乱；后者是一家专注于治疗心脏病患者组织缺氧问题的企业。此前，从1999年到2007年5月，Larkin先生从2002年到2012年任职于Davita, Inc.以及Novasys Medical, Inc.董事会，前者是一家纽交所上市的透析服务提供商；后者是一家专注于女性健康创新性疗法开发的私有企业。自2006年7月，Larkin先生在Cutlass Capital担任风险合伙人，该公司是一家健康护理风险资本公司，同时自2002年1月在Synecor担任执行委员会成员，该公司是一家创新性早期医疗技术开发公司。Larkin先生在Nellcor Puritan Bennett, Inc（重要护理设备生产公司）任职大约15年，他1983年加入该公司并担任负责销售和市场营销的副总裁。他在1989年被任命为Nellcor的总裁以及首席执行官。Larkin先生随后担任Eunoe, Inc.的董事会主席以及首席执行官，该公司是一家专注于神经紊乱的公司，他一直担任此职务到2005年该公司被Integra LifeSciences Holdings Corporation收购。Larkin先生，拉萨尔大学（LaSalle University）工业管理学，同时是美国海军陆战队前上校。
C. Raymond Larkin, Jr. currently serves as a principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. Previously, Mr. Larkin was Chairman and CEO at Eunoe, Inc. He also served as a part time Venture Partner at Cutlass Capital, from 2001 to 2007. Prior to Eunoe, Inc, he was President and CEO of Nellcor Puritan Bennett, Inc., a respiratory product company, which grew to nearly $1 billion in revenues during his tenure through the development and introduction of pulse oximetry for patient safety monitoring.Mr. Larkin earned his B.S. degree in Industrial Management from LaSalle University and served in the United States Marine Corps, rising to the level of Capitan. - C. Raymond Larkin, Jr.自2008年10月担任HeartWare的董事，自2010年6月担任董事会主席。Larkin先生在2004年3月加入Align Technology, Inc.（纳斯达克（Nasdaq）代码：ALGN）董事会，自2006年6月担任董事会主席。Align Technology专注于新型畸齿矫正产品的设计、生产和市场营销。他是Neuropace和TherOx的董事，前者是一家私有的可植入设备的生产商，这些设备主要用于治疗神经紊乱；后者是一家专注于治疗心脏病患者组织缺氧问题的企业。此前，从1999年到2007年5月，Larkin先生从2002年到2012年任职于Davita, Inc.以及Novasys Medical, Inc.董事会，前者是一家纽交所上市的透析服务提供商；后者是一家专注于女性健康创新性疗法开发的私有企业。自2006年7月，Larkin先生在Cutlass Capital担任风险合伙人，该公司是一家健康护理风险资本公司，同时自2002年1月在Synecor担任执行委员会成员，该公司是一家创新性早期医疗技术开发公司。Larkin先生在Nellcor Puritan Bennett, Inc（重要护理设备生产公司）任职大约15年，他1983年加入该公司并担任负责销售和市场营销的副总裁。他在1989年被任命为Nellcor的总裁以及首席执行官。Larkin先生随后担任Eunoe, Inc.的董事会主席以及首席执行官，该公司是一家专注于神经紊乱的公司，他一直担任此职务到2005年该公司被Integra LifeSciences Holdings Corporation收购。Larkin先生，拉萨尔大学（LaSalle University）工业管理学，同时是美国海军陆战队前上校。
- C. Raymond Larkin, Jr. currently serves as a principal of Group Outcome L.L.C., a merchant banking firm concentrating on medical technologies. Previously, Mr. Larkin was Chairman and CEO at Eunoe, Inc. He also served as a part time Venture Partner at Cutlass Capital, from 2001 to 2007. Prior to Eunoe, Inc, he was President and CEO of Nellcor Puritan Bennett, Inc., a respiratory product company, which grew to nearly $1 billion in revenues during his tenure through the development and introduction of pulse oximetry for patient safety monitoring.Mr. Larkin earned his B.S. degree in Industrial Management from LaSalle University and served in the United States Marine Corps, rising to the level of Capitan.
- Andrea L. Saia
-
Andrea L. Saia， 2011-2012年担任诺华公司爱尔康分部视力护理全球主管，在CibaVision Corporation（诺华公司+$2Bio子公司）担任各种高级领导职务，包括总裁兼首席执行官（2008-2011年），欧洲、中东和非洲业务总裁（2005-2007年），全球镜头业务总裁（2003-2005年）和全球营销主管（2002-2003年），以及联合利华的各种高级管理职务。宝洁（Procter & Gamble）和露华浓（revlon）。Saia在凯洛格商学院获得工商管理硕士学位，在迈阿密大学获得工商管理学士学位。
Andrea L. Saia previously served as the Global Head of Vision Care 2011-2012 for the Alcon division of Novartis AG, at CibaVision Corporation, a +$2Bio subsidiary of Novartis in a variety of senior leadership roles, including President and CEO (2008-2011), President of Europe, Middle East, and Africa operations (2005-2007), President of the Global Lens Business (2003-2005) and Global Head of Marketing (2002-2003), and in a variety of senior executive roles with Unilever, Procter & Gamble and Revlon.Ms. Saia earned an M.B.A. from J.L. Kellogg Graduate School of Business and a B.S. in Business Administration from Miami University. - Andrea L. Saia， 2011-2012年担任诺华公司爱尔康分部视力护理全球主管，在CibaVision Corporation（诺华公司+$2Bio子公司）担任各种高级领导职务，包括总裁兼首席执行官（2008-2011年），欧洲、中东和非洲业务总裁（2005-2007年），全球镜头业务总裁（2003-2005年）和全球营销主管（2002-2003年），以及联合利华的各种高级管理职务。宝洁（Procter & Gamble）和露华浓（revlon）。Saia在凯洛格商学院获得工商管理硕士学位，在迈阿密大学获得工商管理学士学位。
- Andrea L. Saia previously served as the Global Head of Vision Care 2011-2012 for the Alcon division of Novartis AG, at CibaVision Corporation, a +$2Bio subsidiary of Novartis in a variety of senior leadership roles, including President and CEO (2008-2011), President of Europe, Middle East, and Africa operations (2005-2007), President of the Global Lens Business (2003-2005) and Global Head of Marketing (2002-2003), and in a variety of senior executive roles with Unilever, Procter & Gamble and Revlon.Ms. Saia earned an M.B.A. from J.L. Kellogg Graduate School of Business and a B.S. in Business Administration from Miami University.
高管简历
中英对照 | 中文 | 英文- Joseph M. Hogan
Joseph M. Hogan ， Align公司总裁兼首席执行官，2015年至今。2008-2013年，ABB公司的首席执行官。2000-2008年通用电气医疗保健公司首席执行官。
Joseph M. Hogan,President and CEO, Align Technology Inc. (dental technology company) CEO, ABB at Cutlass Capital (technology company),2015 - Present.Various Positions including CEO of GE Healthcare, General Electric (a medical technology company),Prior.Supervisory Board of avateramedical N.V. (2019-2021).B.S. in Business and Economics from Geneva College;M.B.A. from Robert Morris University.- Joseph M. Hogan ， Align公司总裁兼首席执行官，2015年至今。2008-2013年，ABB公司的首席执行官。2000-2008年通用电气医疗保健公司首席执行官。
- Joseph M. Hogan,President and CEO, Align Technology Inc. (dental technology company) CEO, ABB at Cutlass Capital (technology company),2015 - Present.Various Positions including CEO of GE Healthcare, General Electric (a medical technology company),Prior.Supervisory Board of avateramedical N.V. (2019-2021).B.S. in Business and Economics from Geneva College;M.B.A. from Robert Morris University.
- John F. Morici
John F. Morici，Align首席财务官兼全球财务执行副总裁，2022年至今。Align全球财务首席财务官兼高级副总裁，2018-2022年。Align首席财务官，2016-2018年。2014-2016年，NBC环球执行副总裁兼董事总经理。2011-2014年，NBC环球首席财务官/首席运营官。NBC环球公司高级副总裁兼首席财务官，2007-2011年。
John F. Morici,Chief Financial Officer and Executive Vice President, Global Finance of Align, 2022-Present. Chief Financial Officer and Senior Vice President, Global Finance of Align, 2018-2022. Chief Financial Officer of Align, 2016-2018. Executive Vice President and Managing Director of NBC Universal, 2014-2016. Chief Financial Officer/Chief Operating Officer of NBC Universal, 2011-2014. Senior Vice President and Chief Financial Officer of NBC Universal, 2007-2011.- John F. Morici，Align首席财务官兼全球财务执行副总裁，2022年至今。Align全球财务首席财务官兼高级副总裁，2018-2022年。Align首席财务官，2016-2018年。2014-2016年，NBC环球执行副总裁兼董事总经理。2011-2014年，NBC环球首席财务官/首席运营官。NBC环球公司高级副总裁兼首席财务官，2007-2011年。
- John F. Morici,Chief Financial Officer and Executive Vice President, Global Finance of Align, 2022-Present. Chief Financial Officer and Senior Vice President, Global Finance of Align, 2018-2022. Chief Financial Officer of Align, 2016-2018. Executive Vice President and Managing Director of NBC Universal, 2014-2016. Chief Financial Officer/Chief Operating Officer of NBC Universal, 2011-2014. Senior Vice President and Chief Financial Officer of NBC Universal, 2007-2011.
- Stuart Hockridge
Stuart Hockridge，Align全球人力资源执行副总裁，2022年至今。2018-2022年Align全球人力资源高级副总裁。Align全球人力资源副总裁，2016-2018年。2013-2016年，Visa人才副总裁。
Stuart Hockridge,Executive Vice President, Global Human Resources of Align, 2022-Present. Senior Vice Present, Global Human Resources of Align, 2018-2022. Vice President, Global Human Resources of Align, 2016-2018. Vice President of Talent of Visa, 2013-2016.- Stuart Hockridge，Align全球人力资源执行副总裁，2022年至今。2018-2022年Align全球人力资源高级副总裁。Align全球人力资源副总裁，2016-2018年。2013-2016年，Visa人才副总裁。
- Stuart Hockridge,Executive Vice President, Global Human Resources of Align, 2022-Present. Senior Vice Present, Global Human Resources of Align, 2018-2022. Vice President, Global Human Resources of Align, 2016-2018. Vice President of Talent of Visa, 2013-2016.
- Julie Coletti
Julie Coletti, Align的执行副总裁、首席法律和监管官（2022年至今）。Align高级副总裁、首席法律和监管官（2019-2022）。Align副总裁，战略商业事务副总法律顾问，2018-2019年。2013-2017年，Danaher副总裁、全球总法律顾问兼首席合规官。2007-2013年，拜耳医疗保健公司MEDRAD/放射学和介入部门的副总裁、首席法务官兼公司秘书。
Julie Coletti,Executive Vice President, Chief Legal and Regulatory Officer of Align, 2022-Present. Senior Vice President, Chief Legal and Regulatory Officer of Align, 2019-2022. Vice President, Associate General Counsel, Strategic Commercial Affairs of Align, 2018-2019. Vice President, Global General Counsel and Chief Compliance Officer of Danaher, 2013-2017. Vice President, Chief Legal Officer and Corporate Secretary of Bayer HealthCare's MEDRAD/Radiology and Interventional Division, 2007-2013.- Julie Coletti, Align的执行副总裁、首席法律和监管官（2022年至今）。Align高级副总裁、首席法律和监管官（2019-2022）。Align副总裁，战略商业事务副总法律顾问，2018-2019年。2013-2017年，Danaher副总裁、全球总法律顾问兼首席合规官。2007-2013年，拜耳医疗保健公司MEDRAD/放射学和介入部门的副总裁、首席法务官兼公司秘书。
- Julie Coletti,Executive Vice President, Chief Legal and Regulatory Officer of Align, 2022-Present. Senior Vice President, Chief Legal and Regulatory Officer of Align, 2019-2022. Vice President, Associate General Counsel, Strategic Commercial Affairs of Align, 2018-2019. Vice President, Global General Counsel and Chief Compliance Officer of Danaher, 2013-2017. Vice President, Chief Legal Officer and Corporate Secretary of Bayer HealthCare's MEDRAD/Radiology and Interventional Division, 2007-2013.
- Emory M. Wright
Emory M. Wright， Align全球运营执行副总裁，2022年至今。Align全球业务高级副总裁，2018-2022年。2007-2018年，Align运营副总裁。2000-2007年在Align担任各种职务，包括制造副总裁。
Emory M. Wright,Executive Vice President, Global Operations of Align, 2022-Present. Senior Vice President, Global Operations of Align, 2018-2022. Vice President, Operations of Align, 2007-2018. Various roles at Align including Vice President, Manufacturing, 2000-2007.- Emory M. Wright， Align全球运营执行副总裁，2022年至今。Align全球业务高级副总裁，2018-2022年。2007-2018年，Align运营副总裁。2000-2007年在Align担任各种职务，包括制造副总裁。
- Emory M. Wright,Executive Vice President, Global Operations of Align, 2022-Present. Senior Vice President, Global Operations of Align, 2018-2022. Vice President, Operations of Align, 2007-2018. Various roles at Align including Vice President, Manufacturing, 2000-2007.